Outbreak
Optimizing vaccine rollout: Should we be concerned about taking possibly less effective — but easier to distribute — COVID shots like AstraZeneca’s and J&J’s?
Yusuff Adebayo Adebisi knows that a vaccine that offers 70% protection against COVID-19 could be a valuable tool against the ...
Is the flu more dangerous than COVID, as many people believe? Study shows risk of COVID death is 3.5 times higher
"We can now say definitively that COVID-19 is much more severe than seasonal influenza," said… Dr. Amol Verma, a researcher ...
What you need to know about the one-shot vaccine by Johnson & Johnson
More than two months after its last COVID-19 vaccine authorization, the FDA authorized for emergency use a one-shot vaccine from ...
Could vaccines accelerate the evolution of more dangerous mutant COVID variants?
Some scientists have argued that it would be better to use the scarce vaccines to give first doses to as ...
Hundreds of novel coronaviruses likely lurking in animal species around the world
[New research] identifies hundreds of animal species that may become infected with known coronaviruses, although many of these infections haven't ...
Long COVID: Some people may never fully recover
They hadn’t been hospitalized. They were relatively young and otherwise in good health, without the underlying conditions like obesity and ...
Emerging symptoms of COVID: Stuttering, forgetfulness, mania, and even psychosis
An early survey of 153 COVID-19 patients in the U.K. and a more recent preprint study of people hospitalized with ...
Reality dawning: COVID will alter how we live for years or decades to come
The ease with which the coronavirus spreads, the emergence of new strains and poor access to vaccines in large parts ...
Playing ‘wait and see’ with the COVID vaccine? Here’s the variety of reasons why people report hesitancy
31% of the public say that when an FDA-approved vaccine for COVID-19 is available to them for free, they will ...
Did closing schools cost lives?
Killing people? Because of several months of Zoom school? How could that be? Well, there is a well-documented association between ...
Viewpoint: An open economy by April? Why the US could reach COVID herd immunity by spring
[COVID] cases are down 77% over the past six weeks. If a medication slashed cases by 77%, we’d call it ...
Infographic: How dangerous COVID mutant strains develop
Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
‘Wait and see?’ 41% of Black women have reservations about COVID shots, 50% of African Americans don’t trust US healthcare system
The latest from the KFF COVID-19 Vaccine Monitor finds that Black men (45%) and women (41%) are more likely than ...
Bubble bursting: Is vitamin D an effective treatment for COVID-19?
The case is simple: we know vitamin D – the “sunshine vitamin” – is involved in immune function, so could it ...
Catching COVID from food: A year’s worth of research dispels panic
When the COVID-19 pandemic began, not much was known about SARS-CoV-2 (the coronavirus) and its survival in food, on various materials ...
How COVID is revolutionizing vaccine development and production
According to Charles Christy, head of commercial solutions, Ibex Dedicate, Lonza, the response to the COVID-19 pandemic has been driving ...
Politics and COVID: Why are Republicans more hesitant to get the vaccine?
Unfortunately, a partisan split on receiving a Covid-19 vaccine has reemerged and widened over the last few months. This partisan ...
Viewpoint: Tanzania’s anti-vaxxer president is slowing COVID response and endangering lives
In politics, there are generally two ways of making decisions. The first is evidence-based, weighing the pros and cons and ...
Antibody treatments: Vaccines are in demand while other effective drugs go unused. Here’s why
Hospitals and clinics, staggered by the needs of the sick and gearing up to help administer the new coronavirus vaccines, ...
‘Cancer is a life sentence. But Covid is a death sentence’: Patients with compromised immune systems unable to access vaccines
Facing conflicting guidance and logistical chaos, many cancer patients are struggling to navigate the bumpy rollout of the Covid-19 vaccination ...
COVID vaccine hesitancy vs vaccine refusal? Many nursing home staff take a wait-and-see position
In North Carolina, the health secretary has said more than half of nursing home workers are declining the vaccine. A ...
How might COVID’s ‘second wave’ play out? 1918-19 Spanish flu pandemic offers bracing precedent
[An] interdisciplinary team [from the University of Zurich and the University of Toronto] compared the Spanish flu of 1918 and ...
‘We don’t know what we don’t know’: Next slate of vaccines might be better at fighting new COVID variations
Now, a year after the pandemic first erupted, three COVID vaccines have been given emergency authorization by either the U.S ...
With widespread COVID vaccine hesitancy, the US may never reach herd immunity. Where will that leave us?
For COVID-19, the herd-immunity threshold is estimated to be between 60 and 90 percent. That’s the proportion of people who ...
I got my COVID-19 vaccine. Can I still get and transmit the virus?
There are two main types of immunity you can achieve with vaccines. One is so-called "effective" immunity, which can prevent ...
Common anti-depressant pill Luvox shows promise in preventing serious COVID infections
A commonly prescribed pill — approved more than 13 years ago by the Food and Drug Administration for depression and ...
We’ve made remarkable progress developing vaccines but treatments for COVID victims remain elusive
The only fully approved COVID-19 drug, the antiviral remdesivir, has shown modest benefit, at best, in hospitalized patients. Two “monoclonal ...
